标题
Tuberculosis drug discovery in the post-post-genomic era
作者
关键词
-
出版物
EMBO Molecular Medicine
Volume -, Issue -, Pages n/a-n/a
出版商
EMBO
发表日期
2014-01-08
DOI
10.1002/emmm.201201772
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species
- (2013) Francisco J. Roca et al. CELL
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Tuberculosis
- (2013) Alimuddin Zumla et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
- (2013) Katherine A. Abrahams et al. PLoS One
- Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3
- (2013) Modesto J. Remuiñán et al. PLoS One
- Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
- (2013) F. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
- (2012) Sarah A. Stanley et al. ACS Chemical Biology
- A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicating Mycobacterium tuberculosis
- (2012) Puiying A. Mak et al. ACS Chemical Biology
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
- (2012) Kapil Tahlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Streptomycin-Starved Mycobacterium tuberculosis 18b, a Drug Discovery Tool for Latent Tuberculosis
- (2012) Ming Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
- (2012) David M. Tobin et al. CELL
- A New Drug for an Old Bug
- (2012) Peter J. Myler et al. CHEMISTRY & BIOLOGY
- Pathway-Selective Sensitization of Mycobacterium tuberculosis for Target-Based Whole-Cell Screening
- (2012) Garth L. Abrahams et al. CHEMISTRY & BIOLOGY
- Structure-Guided Discovery of Phenyl-diketo Acids as Potent Inhibitors of M. tuberculosis Malate Synthase
- (2012) Inna V. Krieger et al. CHEMISTRY & BIOLOGY
- Back to the future: a new ‘old’ lead for tuberculosis
- (2012) Gerard D. Wright EMBO Molecular Medicine
- Towards a new tuberculosis drug: pyridomycin - nature's isoniazid
- (2012) Ruben C. Hartkoorn et al. EMBO Molecular Medicine
- Recent advances in antitubercular natural products
- (2012) Abraham García et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Host gene-encoded severe lung TB: from genes to the potential pathways
- (2012) M Ganachari et al. GENES AND IMMUNITY
- Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of Mycobacterium tuberculosis in Human Macrophages
- (2012) H. Bruns et al. JOURNAL OF IMMUNOLOGY
- Adjunct Immunotherapies for Tuberculosis
- (2012) M. Uhlin et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
- (2012) Anna E Grzegorzewicz et al. Nature Chemical Biology
- Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment
- (2012) A. K. Coussens et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection and treatment of subclinical tuberculosis
- (2012) Brian D. Robertson et al. TUBERCULOSIS
- MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
- (2011) Valentina La Rosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
- (2011) Ruth J. Napier et al. Cell Host & Microbe
- High-content screening in infectious diseases
- (2011) Priscille Brodin et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Tuberculosis drugs: new candidates and how to find more
- (2011) Claudia Sala et al. Future Microbiology
- Express Path Analysis Identifies a Tyrosine Kinase Src-centric Network Regulating Divergent Host Responses toMycobacterium tuberculosisInfection
- (2011) Ahmad Faisal Karim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial
- (2011) Adrian R Martineau et al. LANCET
- Depletion of antibiotic targets has widely varying effects on growth
- (2011) J.-R. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vitamin D Is Required for IFN- -Mediated Antimicrobial Activity of Human Macrophages
- (2011) M. Fabri et al. Science Translational Medicine
- Local pulmonary immunotherapy with siRNA targeting TGFβ1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice
- (2011) Adrian G. Rosas-Taraco et al. TUBERCULOSIS
- Phosphodiesterase-4 Inhibition Alters Gene Expression and Improves Isoniazid – Mediated Clearance of Mycobacterium tuberculosis in Rabbit Lungs
- (2011) Selvakumar Subbian et al. PLoS Pathogens
- Simple Model for Testing Drugs against Nonreplicating Mycobacterium tuberculosis
- (2010) C. Sala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
- (2010) David M. Tobin et al. CELL
- Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis
- (2010) Dhiraj Kumar et al. CELL
- Global tuberculosis drug development pipeline: the need and the reality
- (2010) Zhenkun Ma et al. LANCET
- Leads for antitubercular compounds from kinase inhibitor library screens
- (2010) Sophie Magnet et al. TUBERCULOSIS
- TubercuList – 10 years after
- (2010) Jocelyne M. Lew et al. TUBERCULOSIS
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
- (2010) Kevin Pethe et al. Nature Communications
- Identification of Host-Dependent Survival Factors for Intracellular Mycobacterium tuberculosis through an siRNA Screen
- (2010) Shilpi Jayaswal et al. PLoS Pathogens
- Application of Fragment Growing and Fragment Linking to the Discovery of Inhibitors ofMycobacterium tuberculosisPantothenate Synthetase
- (2009) Alvin W. Hung et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor
- (2009) E. Huitric et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Aligning Antimicrobial Drug Discovery with Complex and Redundant Host-Pathogen Interactions
- (2009) Sarah L. Lebeis et al. Cell Host & Microbe
- Animal models of tuberculosis
- (2009) Douglas Young EUROPEAN JOURNAL OF IMMUNOLOGY
- Synthetic EthR inhibitors boost antituberculous activity of ethionamide
- (2009) Nicolas Willand et al. NATURE MEDICINE
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
- (2009) Thierry Christophe et al. PLoS Pathogens
- Selective Killing of Nonreplicating Mycobacteria
- (2008) Ruslana Bryk et al. Cell Host & Microbe
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More